Aspargo Laboratories
's headquarters is located in Englewood, New Jersey. Michael Demurjian is the Founder & CEO of Aspargo Laboratories. Aspargo Laboratories has received a total of $235K in funding. Aspargo Laboratories's most recent acquisition was Laboratorios Rubio S.A's Bandol for an undisclosed amount on May 2022. Aspargo Laboratories has 2 followers on Owler.Aspargo Laboratories
's headquarters is located in Englewood, New Jersey. Michael Demurjian is the Founder & CEO of Aspargo Laboratories. Aspargo Laboratories has received a total of $235K in funding. Aspargo Laboratories's most recent acquisition was Laboratorios Rubio S.A's Bandol for an undisclosed amount on May 2022. Aspargo Laboratories has 2 followers on Owler.
News
Apr 15, 2025
GlobeNewswire
Press Release: Aspargo Laboratories : Aspargo Labs CEO to Participate in Panel Discussion at the American Urological Association Innovation Nexus Conference
Apr 07, 2025
Benzinga
Aspargo Laboratories: Aspargo Labs Expands Global Leadership Team
Jan 14, 2025
Seeking Alpha
Aspargo Laboratories: Aspargo Labs Aims For Direct Listing On Little Revenue
Jan 10, 2025
Seeking Alpha
Aspargo Laboratories: Aspargo Labs files to go public via direct offering
Jul 30, 2024
Business Wire
Press Release: Aspargo Laboratories : Aspargo Labs Announces Data on First Oral Spray for Erectile Dysfunction, ASP-001, Showing Two Times Faster Absorption Compared to Viagra Tablets
Dec 05, 2023
GlobalNewswire
Press Release: Aspargo Laboratories : Aspargo Laboratories Inc. Announces Completion of Dosing of All Subjects in Sildenafil Oral Suspension Bioavailability Study and Initiation of Dosing in Companion Food-Effect Study
Sep 19, 2023
GlobalNewswire
Press Release: Aspargo Laboratories : Aspargo Laboratories Inc. Announces Initial Dosing of All Subjects in Bioavailability Study for Sildenafil Oral Suspension
Sep 05, 2023
GlobalNewswire
Press Release: Aspargo Laboratories : Aspargo Laboratories Announces IND Clearance by U.S. FDA, Enabling Launch of Bioequivalence and Food-Effect Studies for Sildenafil Oral Spray
Aug 01, 2023
GlobalNewswire
Press Release: Aspargo Laboratories : Aspargo Laboratories, Inc. Announces Filing of Its Investigational New Drug Application for Sildenafil Oral Spray
Jan 24, 2023
GlobalNewswire
Press Release: Aspargo Laboratories : Aspargo Receives Regulatory Approval to Market Sildenafil Spray in Germany, Ireland, and The Netherlands